Bronchiolitis Obliterans Syndrome (BOS) Completed Phase 4 Trials for Montelukast (DB00471)

Also known as: Bronchiolitis Obliterans (BO) / Bronchiolitis Obliterans / Obliterative Bronchiolitis / Bronchiolitis Obliterans Syndrome / Obliterating fibrous bronchiolitis (disorder) / Bronchiolitis fibrosa obliterans (disorder) / Obliterative bronchiolitis (disorder)

IndicationStatusPhase
DBCOND0071683 (Bronchiolitis Obliterans Syndrome (BOS))Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01211509Montelukast in Bronchiolitis Obliterans SyndromeTreatment